Search
for

    GlossaryAbscisic Acid (ABA)

    plant hormone regulating stress responses and seed dormancy

    Abscisic Acid (ABA) is a plant hormone that plays a crucial role in regulating various plant processes, including seed dormancy, stress responses, and stomatal closure. It helps plants adapt to environmental stress conditions such as drought by signaling the closure of stomata to reduce water loss.

    Related Terms

    Learn

    1 / 1 results

    Research

    5 / 1000+ results

    Community Join

    5 / 124 results

      community If you had to abandon DHT blockers, what’s next?

      in Treatment  62 upvotes 6 days ago
      Users discuss alternatives to DHT blockers for hair loss, suggesting minoxidil, microneedling, natural DHT blockers, and scalp massages. Some explore RU58841, ketoconazole, hair transplants, and hair systems due to side effects from finasteride and dutasteride.

      community Kintor does not have abandoned KX-826 - ANNUAL RESULTS 2023

      in Product  7 upvotes 1 year ago
      The conversation discusses disappointment with the hair loss treatment KX-826 but notes that the company Kintor is still focused on developing and commercializing it, as stated in their 2023 annual report. The user questions the effectiveness of KX-826 in comparison to minoxidil's role in improving hair thickness and appearance.

      community Has anyone tried this brand for ru?

      in Product  6 upvotes 4 months ago
      The conversation is about a user experiencing hair shedding after using a brand of RU58841, questioning its effectiveness and safety. Concerns are raised about RU58841 being an abandoned research chemical and the use of heavy oils like castor and argan oil potentially affecting absorption.

      community The story of RU58841/PSK3841

      in Research/Science 1 year ago
      RU58841, an anti-androgenic compound, showed early promise for treating alopecia but faced challenges after its patent in 1997. Despite advancing to Phase II trials, safety concerns and financial struggles led Aventis to abandon its development. Proskelia, which later merged into ProStrakan, couldn't prioritize the drug, leading to its eventual stagnation and failure to reach the market.